Has everyone read BTA's US corporate presentation - it's really well put together- very exciting indeed -http://www.biota.com.au/uploaded/154/1021614_681001uscorporatepresenta.pdf
love this section -
Stockpile market: growth driver
The stockpile is ~US$8B globally and has been built over 4/5 years
Stockpile initiated in 2004 by World Health Organization (WHO)
Approx 60 countries intend to/or carry stockpiles
WHO recommended the initial size of national stockpiles
One course for 25% of population
U.S. stockpile has not achieved that target currently ~22%; c.f. France 33%,
UK 35%(intention to 50%), Australia 55%.
WHO recommends increasing percentage coverage of the population as
capacity/funding permits
Relenzas percentage of the stockpile is increasing due to:
Drug interactions and side effects with oseltamivir
Concerns of oseltamivir resistance
To date, 28 H1N1 pandemic viruses resistant to oseltamivir have been detected (now 206 )
and characterized worldwide**
All of these viruses show the same H275Y mutation that confers resistance to
oseltamivir, but not to zanamivir
Rebalancing from 15:85 Relenza:Tamiflu towards 50:50
*
- Forums
- ASX - By Stock
- BTA
- us corporate presentation is excellent
us corporate presentation is excellent
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online